For those who have not experienced a migraine, perhaps it would seem just another headache. But for someone like me who has suffered through migraines that will last over a week even with medication, I can definitely tell you that it's much more. The ache is not confined to the head; it's the whole experience. Nausea, sensitivity to light, and throbs so bad it makes simple tasks unbearable. It also comes with an emotional burden—the loneliness and frustration are pretty unbearable. Through the years, realizing how hormones are also implicated in triggering and exacerbating my migraines has helped change the game in my dealing with these episodes.

What are Hormonal Migraines?

Hormonal migraines are caused by fluctuations in estrogen and progesterone, the two main female hormones. These hormones are essential for the reproductive system, regulating menstrual cycles and pregnancy. They also have an effect on brain chemicals, such as serotonin and dopamine, which affect mood and pain perception. When hormone levels fluctuate, such as during menstruation, pregnancy, or menopause, they can destabilize the pathways in the brain, causing migraines.

According to Dr. Shivananda Pai, Consultant Neurology, migraines are more than a neurological disorder. "Migraines represent a complex interplay of genetic, environmental, and hormonal factors. In women, hormonal fluctuations are a critical trigger that amplifies sensitivity to pain," he explains. Hormonal headaches are particularly challenging because they are influenced by multiple life stages, from puberty to post-menopause. Common causes include:

• Menstrual periods: Estrogen levels significantly drop just before menstruation often triggers a migraine.
• Pregnancy: Hormones can act to relieve symptoms or aggravate them during different times of pregnancy.
• Menopause: The hormonal fluctuation during menopause can intensify a migraine, while some women tend to find relief.
• Hormonal therapies: Birth control and HRT tend to level off hormone balances in some individuals but will exacerbate a migraine in others.

Complex Role of Hormones in Women’s Neurological Health

Estrogen and Neurological Health

Estrogen, often called the "hormone of femininity", does more than regulate reproductive functions. It is a powerful influencer of brain health. Estrogen modulates the activity of neurotransmitters like serotonin, which regulates mood and pain perception, and dopamine, associated with reward and pleasure.

During stages of hormonal stability, like in pregnancy's latter months, women may have fewer migraines because of the steady elevation of estrogen. However, a sudden downfall in estrogen destabilizes these chemicals in the brain, sending a heightened sensitivity for migraine triggers.

Menstrual Migraines

The most common form of hormonal migraines is menstrual migraines, which occur in response to the steep decline in estrogen levels just before menstruation. These are typically more intense and less responsive to standard treatment. The timing of these migraines provides clear evidence of the role hormones play in neurological health.

Pregnancy and Hormonal Shifts

Pregnancy is a rollercoaster of hormones. Although many women experience relief from migraines as a result of the constantly elevated levels of estrogen, some women, particularly in the first trimester, worsen. This individual variability is a characteristic of hormonal migraine triggers.

Hormonal Therapies and Management of Migraine

Hormonal treatments, such as oral contraceptives and HRT, have had mixed reviews regarding their use in managing migraine. Some women fare better with the stabilization the treatment provides, whereas others suffer worsening symptoms. This will depend on the nature and dose of the hormones used.

Post-Menopause: Migraine Remission or Continued Struggles?

For most women, menopause brings relief from their migraines. The decline in frequency and severity often accompanies stability in hormone levels. Even so, the susceptibility remains with some towards other forms of triggers including stress and sleep deprivation, not to forget diet-related factors and continues the saga of migraines well after the menopausal stages.

Effect on Neurological Health Due to Hormonal Changes

The relationship of hormones to neurological health goes beyond migraines. Hormonal changes have profound effects on a woman's brain in general.

Mood Disorders: Estrogen helps stabilize mood by regulating serotonin. Its decline at menopause increases the risk of mood swings and depression.

Neurodegenerative Diseases: Estrogen is neuroprotective, stimulating the growth and repair of brain cells. Its absence in post-menopausal women has been associated with an increased risk of Alzheimer's disease and cognitive decline.

Multiple Sclerosis (MS): Hormonal cycles may affect the course of MS, a disease that occurs more frequently in women than in men. Estrogen's anti-inflammatory effects provide transient protection during pregnancy, reducing relapse rates in women with MS.

"The intricate interplay between hormones and neurological health underscores the need for gender-specific treatment approaches," says Dr. Pai.

Managing Hormonal Migraines: Practical Strategies

While hormonal changes are inevitable, several strategies can help manage migraines effectively:

1. Tracking Your Cycle

Understanding your menstrual cycle can help identify patterns and predict when migraines might occur. This knowledge allows for preventive measures, such as scheduling medications or adjusting lifestyle habits.

2. Consulting Specialists

Working with a neurologist or gynecologist can help develop a personalized treatment plan. Options might include hormonal therapies, triptans, or preventive medications tailored to your specific needs.

3. Adopting a Healthy Lifestyle

A well-balanced diet, regular exercise, and stress management are all integral parts of managing migraines. For instance, magnesium-rich foods and hydration can help reduce the frequency and severity of attacks.

4. Exploring Preventive Therapies

For people with severe or frequent migraines, preventive medications, such as beta-blockers or CGRP inhibitors, may be prescribed. These medications stabilize brain activity and therefore reduce the chances of migraine during hormonal fluctuations.

5. Mind-Body Techniques

Techniques like yoga, meditation, and biofeedback can enhance wellness and reduce the debilitating effects of stress-one of the most common migraine triggers.

Research that was once in its embryonic stage continues to shed more light on the role of hormones in migraines and other neurological conditions. Further breakthroughs in genetic testing might enable doctors to predict, at least in a way, how an individual would react to hormonal therapies. The importance of gender-specific approaches is gradually being realized, which involves differentiating between the plight of women with migraines from others.

As Dr. Pai puts it, "Empowering women with knowledge about the hormonal underpinnings of migraines can lead to better, more personalized care. With the right strategies, migraines can be effectively managed, allowing women to lead fuller, healthier lives.

Migraines are not headaches; they are a complex neurological condition that deeply impacts the lives of millions of women. Understanding the role of hormones in triggering and exacerbating migraines is a vital step toward better management and relief.

Awareness, proactive care, and advances in medical research can help women regain their lives from the grip of hormonal migraines. Whether tracking cycles, adopting healthier habits, or seeking tailored medical care, every step taken toward understanding and managing migraines is a step toward empowerment.

Dr Shivananda Pai is a Consultant Neurology at KMC Hospital Dr B R Ambedkar Circle in Mangalore, India.

Brandes JL. The Influence of Estrogen on Migraine: A Systematic Review. JAMA. 2006;295(15):1824–1830. doi:10.1001/jama.295.15.1824

Sacco S, Ricci S, Degan D, Carolei A. Migraine in women: the role of hormones and their impact on vascular diseases. J Headache Pain. 2012 Apr;13(3):177-89. doi: 10.1007/s10194-012-0424-y. Epub 2012 Feb 26. PMID: 22367631; PMCID: PMC3311830.

Bryan Johnson, the billionaire biohacker and longevity enthusiast, has been diagnosed with an incurable autoimmune disease called Autoimmune Gastritis (AIG).

Johnson is known for his radical longevity experiments, including measuring the biological age of his organs in an effort to reverse aging, injecting himself with ketamine, taking over 50 pills a day, undergoing fat transfers, and receiving blood transfusions from his teenage son.

In a recent post on X, he made the shocking announcement of his autoimmune conditions, which went undetected for years: Autoimmune Gastritis.

Calling it "bad news," Johnson wrote: "I have an autoimmune disease. My stomach is eating itself."

"2-5 per cent of people have this, too. Likely more, because it hides," he added.

According to Johnson, his stomach had been attacking itself without causing noticeable symptoms. The condition was only discovered in May.

Also read: Bryan Johnson Blames Sugary Cereals, Soda and Stress for His Autoimmune Disease; Shares Treatment Plan

The Early Warning Sign: Low Ferritin

Autoimmune Gastritis, a condition in which the immune system attacks the stomach's acid-producing cells, also impairs the absorption of iron and vitamin B12.

Johnson said one of the earliest signs of the condition was persistently low ferritin levels over the past 11 years despite not having anemia.

"We continually tried to raise my iron levels with food and supplementation, but nothing would work."

He said he followed a plant-based diet, trained intensely, used a sauna and hyperbaric oxygen therapy, and took iron supplements, yet his iron levels remained low.

Ferritin stores the body's iron. Iron is essential for transporting oxygen and producing energy, and low iron levels can lead to fatigue, weakness, and dizziness.

Johnson said autoimmune gastritis is difficult to diagnose because its earliest clue is often overlooked.

"The earliest clue, low ferritin, is the one standard medicine waves through. Low iron stores get normalized and rarely investigated at all when anemia hasn't shown up yet. That blind spot is what hid mine for a decade."

While initially it wasn't clear why his iron levels were continuously dipping, after further testing, Johnson's team identified three interconnected issues.

Read More: Bryan Johnson Battles Autoimmune Gastritis: Which Parts Of His Longevity Guide Are Actually Worth Copying?

Autoimmune Gastritis was preventing normal iron absorption by damaging the stomach cells that produce acid. He also discovered autoimmune thyroid disease.

"The iron deficiency, the autoimmune gastritis driving it, and the autoimmune thyroid disease alongside it. Iron and thyroid feed each other both ways; low iron impairs the conversion of thyroid hormone into its active form, and an underactive thyroid impairs how the body uses iron," Johnson explained.

Iron Deficiency May Be More Common Than Many Realize

According to research published in JAMA Network Open, about one in four Americans may have inadequate iron intake or absorption.

As per the study of more than 8,000 Americans, 14 per cent of adults had absolute iron deficiency, reflecting depleted iron stores.

Even after excluding common causes such as anemia, pregnancy, heart failure, and chronic kidney disease, 11 per cent remained iron deficient. Another 15 per cent had functional iron deficiency, where iron levels appear normal but the body cannot use the mineral effectively.

How Bryan Johnson Is Managing The Condition

Since receiving the diagnosis, Johnson has begun iron infusions, which deliver a full dose of iron in a single treatment.

He said his team will continue routine monitoring of his ferritin and iron levels.

Johnson ended his post with a warning that hidden health conditions can go unnoticed for years.

"You too may have a lurking health issue that is undiagnosed and could increase in severity from unhealthy life choices, without your knowing… A gentle nudge that minding your health, no matter your situation in life, is a good decision-making."

A recent study has indicated that following a healthy diet consistently may help reduce the risk of dementia, even in those who already show early signs of Alzheimer's disease. The study could help in early management of neurodegenerative diseases like dementia.

Anti-Inflammatory Diet May Help Lower Dementia Risk

According to a new study published in the JAMA Network Open, scientists found that participants who maintained better-quality diets over a period of 15 years were less likely to develop dementia, regardless of whether their blood tests indicated the presence of Alzheimer ’s related biomarkers.

The findings also suggest that healthy eating habits may benefit even after the individual shows signs of the disease processes have begun.

About The Study And Its Results

The researchers followed middle-aged and older adults one and a half decades, examining their dietary habits alongside blood biomarkers associated with Alzheimer's disease, including phosphorylated tau217 (p-tau217), glial fibrillary acidic protein (GFAP), and neurofilament light (NfL).

These biomarkers are commonly used to detect early Alzheimer's-related changes and neurodegeneration before symptoms of the disease become visible.

The participants followed a healthy diet, particularly a Mediterranean-style as well as an anti-inflammatory diet. The findings showed that individuals with healthier diets had a lower risk of developing dementia over the follow-up period.

Remarkably, this association was observed even among participants who presented Alzheimer's biomarkers, indicating that diet may offer protective benefits despite early signs.

Alzheimer's disease begins years, and sometimes decades, before memory problems emerge. During this preclinical stage, abnormal proteins accumulate in the brain while individuals remain symptom-free.

Read more: New Blood Test May Predict Alzheimer's Symptoms At Least 4 Years In Advance: Study

The new findings indicate that lifestyle factors such as diet could still influence dementia risk even after these biological changes have started. This reinforces growing evidence that preventive measures need not be limited to people without detectable Alzheimer's pathology.

Not A Preventative Measure

While the study shows promising results of the effect of a healthy diet on the neurodegenerative disease, it does not prove that diets can directly prevent dementia.

The researchers emphasized that the study was merely an observation, meaning it highlighted an association rather than a direct cause-and-effect relationship. It just supports the idea that long-term healthy eating could have a significant impact on one’s brain health throughout adulthood.

Benefits Of Anti-Inflammatory & Mediterranean Diets

The anti-inflammatory diet, as recommended by Harvard Nutrition Source, helps calm the immune system by choosing foods that reduce inflammation.

This dietary approach encourages a balance of fruits, vegetables, healthy fats, whole grains, and other nutrient-dense foods while avoiding those that trigger inflammation.

On the other hand, Mediterranean diet, long celebrated for its heart-and longevity-promoting benefits, is now gaining attention for its beneficial effects on the brain.

This diet emphasizes plant-based foods, healthy fats such as extra virgin olive oil, nuts, fruits, vegetables, and whole grains, with moderate fish intake.

In another study published in Nature Medicine, researchers observed that individuals at the highest genetic risk for Alzheimer’s disease, particularly carriers of the APOE4 gene variant, showed the most significant reduction in dementia risk when adhering closely to this dietary pattern.

Parkinson’s disease is the second most common neurodegenerative disorder in the world and is the fastest-growing neurological condition worldwide. Its classic hallmarks - resting tremor, bradykinesia, and rigidity usually lead to diagnosis only after extensive dopaminergic neuronal loss has already happened. Newer research, however, highlights a prodromal window that might open decades earlier. There’s an increasing theory that pathological changes of the nervous system could start in a person’s 20s. This means that early detection is not just desirable but could be transformative for clinical outcomes.

Individuals with PD at prodromal and early motor stages alike report symptoms in multiple domains, including behavioral, cognitive, autonomic, sensory, sleep-related, and activities of daily living. Most of these symptoms are subtle and overlap with common conditions, so they aren’t often recognized or are mistaken for ageing, stress or other lifestyle factors. So, identifying consistent patterns amid daily behavioral variations is crucial for improving early PD detection.

Sleep Disturbances: An Early Warning Sign

One of the most robust prodromal markers is REM sleep behavior disorder (RBD). People who are affected have sleep disruption, physically act out their dreams during REM phase (acting out dreams), and vivid dream life and some through sleepwalking — all of them worthy substrates for signals of early brainstem pathology.

Loss of Smell May Appear Years Before Diagnosis

Anosmia, a partial or complete loss of the sense of smell, could be PD’s earliest recognizable sign, occurring as much as 10 years before motor signs become apparent. In practice, this means being unable to easily perceive familiar smells like food or coffee. Because this symptom manifests so early and appears so unrelated to the health of the brain, it is rarely taken seriously in clinical practice.

Gut Changes and the Brain Connection

Chronic constipation is a common prodromal symptom indicating reduced gut motility that can predate motor symptoms by years. This observation is consistent with the gut–brain axis hypothesis: gut microbiota dysbiosis disrupts gastrointestinal motility, permeability and inflammation, which may facilitate a prion-like transmission of misformed alpha-synuclein (α-syn) from gut to brain through the enteric nervous system.1 further underscoring the biomarker potential of gastrointestinal symptoms with clinical relevance.

Subtle Changes in Movement and Mood

Before tremors are apparent, there can be subtle changes in fine motor control. Trouble with tasks such as handwriting, using electronic devices or manipulating small objects, along with uncharacteristic anxiety or a low mood, can serve as signals of the preclinical stage. Micrographia (progressively smaller and cramped handwriting) is a particularly telling sign from daily life that deserves a neurological workup when it appears without an obvious cause.

Fatigue and Autonomic Symptoms Can Precede Motor Signs

Fatigue that never seems to get better with rest affects work performance, social engagement and daily motivation, and can occur long before an official diagnosis. More than half of all PD patients develop at least one form of autonomic dysfunction, which can precede motor symptoms by four years or more, and is now being recognized as a key prognostic biomarker for prodromal PD. Cardiovascular instability, orthostatic hypotension, and urinary irregularities further influence how individuals navigate everyday environments long before a definitive diagnosis is made.

Recognizing Early Signals Can Transform Care

The evidence reviewed here collectively supports a paradigm shift: Parkinson's disease is best defined as systemic, progressive, and with recognizable signals in daily life long before motor signs of decline. Disrupted sleep, anosmia, gastrointestinal changes, fine motor difficulties and chronic fatigue are not complaints in a vacuum; they are potential early signs of a neurological process left unsupervised and now in motion. Incorporating routine clinical assessment of these behavioural precursors and pre-motor signs would allow us to meaningfully extend the opportunity for therapeutic intervention, which could in turn improve patient outcomes across a broad range of CNS disorders.